SRX12813824 GSM5660806 SRP343652 SRS10759127 GSM5660806 RNA-Seq TRANSCRIPTOMIC cDNA Total RNA of human vascular smooth muscle cells were extracted using TRIzol regents and RNA quality was determined using Agilent 2100 Bioanalyser. mRNA molecules were purified from total RNA using oligo (dT)-attached magnetic beads. Then, mRNA molecules were fragmented into small pieces using fragmentation reagent after reaction a certain period in proper temperature. First-strand cDNA was generated using random hexamer-primed reverse transcription, followed by a second-strand cDNA synthesis. The synthesis cDNA was subjected to end-repair and then was 3'-adenylated. Adapters were ligated to the ends of these 3'-adenylated cDNA fragments. PCR was used to amplify the cDNA fragments with adapters from previous step. PCR products were purified with Ampure XP Beads (AGENCOURT), and dissolved in EB solution. Library was validated on the Agilent Technologies 2100 Bioanalysers. BGISEQ-500 gds 305660806 GSM5660806 GEO Accession GSM5660806 SRX12813825 GSM5660807 SRP343652 SRS10759128 GSM5660807 RNA-Seq TRANSCRIPTOMIC cDNA Total RNA of human vascular smooth muscle cells were extracted using TRIzol regents and RNA quality was determined using Agilent 2100 Bioanalyser. mRNA molecules were purified from total RNA using oligo (dT)-attached magnetic beads. Then, mRNA molecules were fragmented into small pieces using fragmentation reagent after reaction a certain period in proper temperature. First-strand cDNA was generated using random hexamer-primed reverse transcription, followed by a second-strand cDNA synthesis. The synthesis cDNA was subjected to end-repair and then was 3'-adenylated. Adapters were ligated to the ends of these 3'-adenylated cDNA fragments. PCR was used to amplify the cDNA fragments with adapters from previous step. PCR products were purified with Ampure XP Beads (AGENCOURT), and dissolved in EB solution. Library was validated on the Agilent Technologies 2100 Bioanalysers. BGISEQ-500 gds 305660807 GSM5660807 GEO Accession GSM5660807 SRX12813826 GSM5660808 SRP343652 SRS10759129 GSM5660808 RNA-Seq TRANSCRIPTOMIC cDNA Total RNA of human vascular smooth muscle cells were extracted using TRIzol regents and RNA quality was determined using Agilent 2100 Bioanalyser. mRNA molecules were purified from total RNA using oligo (dT)-attached magnetic beads. Then, mRNA molecules were fragmented into small pieces using fragmentation reagent after reaction a certain period in proper temperature. First-strand cDNA was generated using random hexamer-primed reverse transcription, followed by a second-strand cDNA synthesis. The synthesis cDNA was subjected to end-repair and then was 3'-adenylated. Adapters were ligated to the ends of these 3'-adenylated cDNA fragments. PCR was used to amplify the cDNA fragments with adapters from previous step. PCR products were purified with Ampure XP Beads (AGENCOURT), and dissolved in EB solution. Library was validated on the Agilent Technologies 2100 Bioanalysers. BGISEQ-500 gds 305660808 GSM5660808 GEO Accession GSM5660808 SRX12813827 GSM5660809 SRP343652 SRS10759130 GSM5660809 RNA-Seq TRANSCRIPTOMIC cDNA Total RNA of human vascular smooth muscle cells were extracted using TRIzol regents and RNA quality was determined using Agilent 2100 Bioanalyser. mRNA molecules were purified from total RNA using oligo (dT)-attached magnetic beads. Then, mRNA molecules were fragmented into small pieces using fragmentation reagent after reaction a certain period in proper temperature. First-strand cDNA was generated using random hexamer-primed reverse transcription, followed by a second-strand cDNA synthesis. The synthesis cDNA was subjected to end-repair and then was 3'-adenylated. Adapters were ligated to the ends of these 3'-adenylated cDNA fragments. PCR was used to amplify the cDNA fragments with adapters from previous step. PCR products were purified with Ampure XP Beads (AGENCOURT), and dissolved in EB solution. Library was validated on the Agilent Technologies 2100 Bioanalysers. BGISEQ-500 gds 305660809 GSM5660809 GEO Accession GSM5660809 SRX12813828 GSM5660810 SRP343652 SRS10759131 GSM5660810 RNA-Seq TRANSCRIPTOMIC cDNA Total RNA of human vascular smooth muscle cells were extracted using TRIzol regents and RNA quality was determined using Agilent 2100 Bioanalyser. mRNA molecules were purified from total RNA using oligo (dT)-attached magnetic beads. Then, mRNA molecules were fragmented into small pieces using fragmentation reagent after reaction a certain period in proper temperature. First-strand cDNA was generated using random hexamer-primed reverse transcription, followed by a second-strand cDNA synthesis. The synthesis cDNA was subjected to end-repair and then was 3'-adenylated. Adapters were ligated to the ends of these 3'-adenylated cDNA fragments. PCR was used to amplify the cDNA fragments with adapters from previous step. PCR products were purified with Ampure XP Beads (AGENCOURT), and dissolved in EB solution. Library was validated on the Agilent Technologies 2100 Bioanalysers. BGISEQ-500 gds 305660810 GSM5660810 GEO Accession GSM5660810 SRX12813829 GSM5660811 SRP343652 SRS10759132 GSM5660811 RNA-Seq TRANSCRIPTOMIC cDNA Total RNA of human vascular smooth muscle cells were extracted using TRIzol regents and RNA quality was determined using Agilent 2100 Bioanalyser. mRNA molecules were purified from total RNA using oligo (dT)-attached magnetic beads. Then, mRNA molecules were fragmented into small pieces using fragmentation reagent after reaction a certain period in proper temperature. First-strand cDNA was generated using random hexamer-primed reverse transcription, followed by a second-strand cDNA synthesis. The synthesis cDNA was subjected to end-repair and then was 3'-adenylated. Adapters were ligated to the ends of these 3'-adenylated cDNA fragments. PCR was used to amplify the cDNA fragments with adapters from previous step. PCR products were purified with Ampure XP Beads (AGENCOURT), and dissolved in EB solution. Library was validated on the Agilent Technologies 2100 Bioanalysers. BGISEQ-500 gds 305660811 GSM5660811 GEO Accession GSM5660811